Application
Western blot analysis of CBP expression in KNRK (A) and Jurkat (B) nuclear extracts.Application
Antibodies tested include CBP (A-22): , p300 (N-15): , PCAF (H-369): , and Brg-1 (H-88): . CD3ε and Oct-2 promoter regions were employed as positive and negative controls, respectively. DNA was isolated from Rag-/- thymocytes or Rag-/- thymocytes expressing TCRβ. Data kindly provided by J. Imbert and reproduced from Yeh, J-H., et al., Nucleic Acids Research, 2002, 30: 1944-1951, with permission from Oxford University Press.Application
Control Input (A). Antibodies used included RORα (C-16): (B), TIP60 (N-17): (C), CBP (A-22): and CBP (C-20): (D). Data kindly provided by M.G. Rosenfeld and reproduced wtih permission from Gold et al., Neuron 2003, 40: 1119-1131.Application
Antibodies tested include NFκB p50 (C-19): , NFκB p50 (E-10): , NFκB p50 (H-119): , NFκB p65 (C-20): , NFκB p65 (A): , NFκB p65 (H-286): , CBP (A-22): , CBP (C-1): , CBP (C-20): , CBP (451): , p300 (C-20): 585, p300 (N-15): 584, p300 (H-272): . Data kindly provided by M.G. Rosenfeld and reproduced with permission from Baek et al., Cell 2002, 110: 55-67.Application
Antibodies tested include NFκB p50 (C-19): , NFκB p50 (E-10): , NFκB p50 (H-119): , NFκB p65 (C-20): , NFκB p65 (A): , NFκB p65 (H-286): , Bcl-3 (C-14): , Bcl-3 (H-146): , PCAF (C-16): , PCAF (H-369): , CBP (A-22): , CBP (C-1): , CBP (C-20): , CBP (451): . Data kindly provided by M.G. Rosenfeld and reproduced with permission from Baek et al., Cell 2002, 110: 55-67.Application
Antibodies tested include ERα (MC-20): , ERα (H-184): , CBP (A-22): , CBP (C-1): , p/CIP (F2): , p/CIP (M-397): , RIP140 (H-300): and HDAC3 (N-19): . Data kindly provided by M.G. Rosenfeld and reproduced with permission from Perissi et al., Cell 2004, 116: 511-526.Application
Antibodies tested include β-catenin (H-102): , β-catenin (C-18): , β-catenin (E-5): , Tip60 (N-17): , TRRAP (T-17): , TRRAP (Y-18): , TRRAP (F-20): , TRRAP (H-300): , CBP (A-22): , CBP (C-20): , CBP (451): , CPB (C-1): , p300 (H-272): , p300 (N-15): and p300 (C-20): . Data kindly provided by M.G. Rosenfeld and reproduced with permission from Kioussi et al., Cell 2002, 111: 673-685.Application
Antibodies tested included NFκB p65 (A): , ATF-2 (N-96): , GCN5 (N-18): , Pol II (H-224): , TFIID (TBP)(SI-1): and CBP (A-22): . Data kindly provided by G. Mosialos.Application
Western blot analysis of CBP expression in KNRK nuclear extract.| Product Name | CBP Antibody (A-22) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | epitope mapping at the N-terminus of CBP of human origin |
| Modification Notes | Cyclic AMP-regulated gene expression frequently involves a DNA element designated the cAMP-regulated enhancer (CRE). Many transcription factors bind to this element, including the protein CREB, which is activated as a result of phosphorylation by protein kinase A. It has been shown that protein kinase A-mediated CREB phosphorylation results in its binding to a nuclear protein designated CBP (for CREB-binding protein). These findings suggest that CBP has many of the properties expected of a CREB co-activator. Another high molecular weight transcriptional adapter protein, designated p300, is characterized by three cysteine- and histidine-rich regions, of which the most carboxy terminal region specifically binds the adenovirus E1A protein. p300 molecules lacking an intact E1A binding site bypass E1A repression, even in the presence of high concentrations of E1A. Sequence analysis of CBP and p300 has revealed substantial homology, arguing that these proteins are members of a conserved family of co-activators. |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WBIPIFELISAGSChIP |
| recommended for detection of CBP p265 of mouse, rat and human origin by WB, IP, IF and ELISA also reactive with additional species, including canine, bovine and porcine: |
|
| Species Reactivity | HumanMouseRat |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Alternative Names | epitope mapping at the N-terminus of CBP of human origin |
|---|---|
| Tissue Specificity | epitope mapping at the N-terminus of CBP of human origin |
| Entrez Gene | 1387 |
|---|
Application
Western blot analysis of CBP expression in KNRK (A) and Jurkat (B) nuclear extracts.
Application
Antibodies tested include CBP (A-22): , p300 (N-15): , PCAF (H-369): , and Brg-1 (H-88): . CD3ε and Oct-2 promoter regions were employed as positive and negative controls, respectively. DNA was isolated from Rag-/- thymocytes or Rag-/- thymocytes expressing TCRβ. Data kindly provided by J. Imbert and reproduced from Yeh, J-H., et al., Nucleic Acids Research, 2002, 30: 1944-1951, with permission from Oxford University Press.
Application
Control Input (A). Antibodies used included RORα (C-16): (B), TIP60 (N-17): (C), CBP (A-22): and CBP (C-20): (D). Data kindly provided by M.G. Rosenfeld and reproduced wtih permission from Gold et al., Neuron 2003, 40: 1119-1131.
Application
Antibodies tested include NFκB p50 (C-19): , NFκB p50 (E-10): , NFκB p50 (H-119): , NFκB p65 (C-20): , NFκB p65 (A): , NFκB p65 (H-286): , CBP (A-22): , CBP (C-1): , CBP (C-20): , CBP (451): , p300 (C-20): 585, p300 (N-15): 584, p300 (H-272): . Data kindly provided by M.G. Rosenfeld and reproduced with permission from Baek et al., Cell 2002, 110: 55-67.
Application
Antibodies tested include NFκB p50 (C-19): , NFκB p50 (E-10): , NFκB p50 (H-119): , NFκB p65 (C-20): , NFκB p65 (A): , NFκB p65 (H-286): , Bcl-3 (C-14): , Bcl-3 (H-146): , PCAF (C-16): , PCAF (H-369): , CBP (A-22): , CBP (C-1): , CBP (C-20): , CBP (451): . Data kindly provided by M.G. Rosenfeld and reproduced with permission from Baek et al., Cell 2002, 110: 55-67.
Application
Antibodies tested include ERα (MC-20): , ERα (H-184): , CBP (A-22): , CBP (C-1): , p/CIP (F2): , p/CIP (M-397): , RIP140 (H-300): and HDAC3 (N-19): . Data kindly provided by M.G. Rosenfeld and reproduced with permission from Perissi et al., Cell 2004, 116: 511-526.
Application
Antibodies tested include β-catenin (H-102): , β-catenin (C-18): , β-catenin (E-5): , Tip60 (N-17): , TRRAP (T-17): , TRRAP (Y-18): , TRRAP (F-20): , TRRAP (H-300): , CBP (A-22): , CBP (C-20): , CBP (451): , CPB (C-1): , p300 (H-272): , p300 (N-15): and p300 (C-20): . Data kindly provided by M.G. Rosenfeld and reproduced with permission from Kioussi et al., Cell 2002, 111: 673-685.
Application
Antibodies tested included NFκB p65 (A): , ATF-2 (N-96): , GCN5 (N-18): , Pol II (H-224): , TFIID (TBP)(SI-1): and CBP (A-22): . Data kindly provided by G. Mosialos.
Application
Western blot analysis of CBP expression in KNRK nuclear extract.| Application Notes | recommended for detection of CBP p265 of mouse, rat and human origin by WB, IP, IF and ELISA also reactive with additional species, including canine, bovine and porcine: |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
